Loading clinical trials...
Loading clinical trials...
The Effectiveness of ACB-IP 1.0 Universal Pathogen Free Concentrated Cocktail Convalescent Plasma in COVID-19 Infection
Conditions
Locations
2
Turkey (Türkiye)
Acıbadem Labcell Cellular Therapy Laboratories
Istanbul, Turkey (Türkiye)
Acibadem Altunizade Hospital
Istanbul, Turkey (Türkiye)
Start Date
February 18, 2021
Primary Completion Date
April 1, 2021
Completion Date
June 1, 2021
Last Updated
February 24, 2021
NCT04525716
NCT03188796
NCT06355232
NCT05191420
NCT04611243
NCT04678193
Lead Sponsor
Acibadem University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions